Follow
Robert Busch
Robert Busch
Roehampton OR Cambridge OR KineMed OR Stanford OR DKFZ OR "German Cancer Research Center" OR
Verified email at roehampton.ac.uk
Title
Cited by
Cited by
Year
Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding.
TS Jardetzky, JC Gorga, R Busch, J Rothbard, JL Strominger, DC Wiley
The EMBO journal 9 (6), 1797-1803, 1990
3171990
Measurement of protein turnover rates by heavy water labeling of nonessential amino acids
R Busch, YK Kim, RA Neese, V Schade-Serin, M Collins, M Awada, ...
Biochimica et Biophysica Acta (BBA)-General Subjects 1760 (5), 730-744, 2006
2882006
Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression
R Busch, CH Rinderknecht, S Roh, AW Lee, JJ Harding, T Burster, ...
Immunological reviews 207 (1), 242-260, 2005
2082005
Measurement of cell proliferation by heavy water labeling
R Busch, RA Neese, M Awada, GM Hayes, MK Hellerstein
Nature protocols 2 (12), 3045-3057, 2007
1972007
Invariant chain protects class II histocompatibility antigens from binding intact polypeptides in the endoplasmic reticulum.
R Busch, I Cloutier, RP Sékaly, GJ Hämmerling
The EMBO journal 15 (2), 418-428, 1996
1881996
Formation of a highly peptide-receptive state of class II MHC
JD Rabinowitz, M Vrljic, PM Kasson, MN Liang, R Busch, JJ Boniface, ...
Immunity 9 (5), 699-709, 1998
1621998
Accessory molecules for MHC class II peptide loading
R Busch, RC Doebele, NS Patil, A Pashine, ED Mellins
Current opinion in immunology 12 (1), 99-106, 2000
1542000
Determination of the HLA-DM interaction site on HLA-DR molecules
RC Doebele, R Busch, HM Scott, A Pashine, ED Mellins
Immunity 13 (4), 517-527, 2000
1532000
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces
R Busch, G Strang, K Howland, JB Rothbard
International Immunology 2 (5), 443-451, 1990
1531990
Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides
A Pashine, R Busch, MP Belmares, JN Munning, RC Doebele, ...
Immunity 19 (2), 183-192, 2003
1302003
Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.
R Busch, CM Hill, JD Hayball, JR Lamb, JB Rothbard
Journal of immunology (Baltimore, Md.: 1950) 147 (4), 1292-1298, 1991
1281991
Developing and shedding inhibitions: how MHC class II molecules reach maturity
R Busch, ED Mellins
Current opinion in immunology 8 (1), 51-58, 1996
1201996
Symptom-based stratification of patients with primary Sjögren's syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised …
JR Tarn, N Howard-Tripp, DW Lendrem, X Mariette, A Saraux, ...
The Lancet Rheumatology 1 (2), e85-e94, 2019
1072019
The kinetic basis of peptide exchange catalysis by HLA-DM
JA Zarutskie, R Busch, Z Zavala-Ruiz, M Rushe, ED Mellins, LJ Stern
Proceedings of the National Academy of Sciences 98 (22), 12450-12455, 2001
912001
Central memory CD8+ T cells appear to have a shorter lifespan and reduced abundance as a function of HIV disease progression
K Ladell, MK Hellerstein, D Cesar, R Busch, D Boban, JM McCune
The Journal of Immunology 180 (12), 7907-7918, 2008
892008
Structural factors contributing to DM susceptibility of MHC class II/peptide complexes
MP Belmares, R Busch, KW Wucherpfennig, HM McConnell, ED Mellins
The Journal of Immunology 169 (9), 5109-5117, 2002
832002
The TRACTISS Protocol: a randomised double blind placebo controlled clinical TRial of Anti-B-Cell Therapy In patients with primary Sjögren’s Syndrome
S Brown, N Navarro Coy, C Pitzalis, P Emery, S Pavitt, J Gray, C Hulme, ...
BMC musculoskeletal disorders 15, 1-10, 2014
742014
Secondary structure composition and pH-dependent conformational changes of soluble recombinant HLA-DM
R Busch, Z Reich, DM Zaller, V Sloan, ED Mellins
Journal of Biological Chemistry 273 (42), 27557-27564, 1998
731998
Structural analysis of a peptide-HLA class II complex: identification of critical interactions for its formation and recognition by T cell receptor
JB Rothbard, R Busch, K Howland, V Bal, C Fenton, WR Taylor, JR Lamb
International immunology 1 (5), 479-486, 1989
711989
Relationship between kinetic stability and immunogenicity of HLA‐DR4/peptide complexes
FC Hall, JD Rabinowitz, R Busch, KC Visconti, M Belmares, NS Patil, ...
European journal of immunology 32 (3), 662-670, 2002
662002
The system can't perform the operation now. Try again later.
Articles 1–20